127 related articles for article (PubMed ID: 38580136)
21. Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responses.
Sheng S; Zhang H; Li X; Chen J; Wang P; Liang Y; Li C; Li H; Pan N; Bao X; Liu M; Zhao L; Li X; Guan P; Wang X
J Nanobiotechnology; 2024 May; 22(1):267. PubMed ID: 38764014
[TBL] [Abstract][Full Text] [Related]
22. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
23. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.
Nembrini C; Stano A; Dane KY; Ballester M; van der Vlies AJ; Marsland BJ; Swartz MA; Hubbell JA
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):E989-97. PubMed ID: 21969597
[TBL] [Abstract][Full Text] [Related]
25. Simple nanoliposomes encapsulating
Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
[TBL] [Abstract][Full Text] [Related]
26. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
27. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
[TBL] [Abstract][Full Text] [Related]
28. Amino-Modified Polymer Nanoparticles as Adjuvants to Activate the Complement System and to Improve Vaccine Efficacy in Vivo.
Pan Y; Qi Y; Shao N; Tadle AC; Huang Y
Biomacromolecules; 2019 Sep; 20(9):3575-3583. PubMed ID: 31415161
[TBL] [Abstract][Full Text] [Related]
29. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo.
Pi CC; Chu CL; Lu CY; Zhuang YJ; Wang CL; Yu YH; Wang HY; Lin CC; Chen CJ
Vaccine; 2014 Jan; 32(3):401-8. PubMed ID: 24252697
[TBL] [Abstract][Full Text] [Related]
30. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
[TBL] [Abstract][Full Text] [Related]
31. Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).
Schmidt ST; Pedersen GK; Neustrup MA; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
Front Immunol; 2018; 9():898. PubMed ID: 29760705
[TBL] [Abstract][Full Text] [Related]
32. Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.
Foster S; Duvall CL; Crownover EF; Hoffman AS; Stayton PS
Bioconjug Chem; 2010 Dec; 21(12):2205-12. PubMed ID: 21043513
[TBL] [Abstract][Full Text] [Related]
33. A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy.
Dong X; Liang J; Yang A; Qian Z; Kong D; Lv F
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4876-4888. PubMed ID: 30628437
[TBL] [Abstract][Full Text] [Related]
34. Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice.
Zhou W; Moguche AO; Chiu D; Murali-Krishna K; Baneyx F
Nanomedicine; 2014 Apr; 10(3):571-8. PubMed ID: 24275478
[TBL] [Abstract][Full Text] [Related]
35. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
Milicic A; Kaur R; Reyes-Sandoval A; Tang CK; Honeycutt J; Perrie Y; Hill AV
PLoS One; 2012; 7(3):e34255. PubMed ID: 22470545
[TBL] [Abstract][Full Text] [Related]
36. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
37. Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.
MacLeod MK; McKee AS; David A; Wang J; Mason R; Kappler JW; Marrack P
Proc Natl Acad Sci U S A; 2011 May; 108(19):7914-9. PubMed ID: 21518876
[TBL] [Abstract][Full Text] [Related]
38. Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.
Chen N; Johnson MM; Collier MA; Gallovic MD; Bachelder EM; Ainslie KM
J Control Release; 2018 Mar; 273():147-159. PubMed ID: 29407676
[TBL] [Abstract][Full Text] [Related]
39. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine.
Johnston D; Bystryn JC
Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898
[TBL] [Abstract][Full Text] [Related]
40. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
